Clinical Trial Update: The Dublin Zepatier Study [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for Zepatier (elbasvir/grazoprevir) in Hepatitis C has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Zepatier (elbasvir/grazoprevir)

Snippet

Sponsor: Mater Misericordiae University Hospital | Conditions: Hepatitis C | Phase 4 | Status: TERMINATED